Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
For Use With (Application)
- (2)
- (2,347)
- (79)
- (3)
- (1)
- (1)
- (9)
- (354)
- (6,256)
- (7)
- (2)
- (7)
- (2)
- (1)
- (1)
- (2)
- (6)
- (41)
- (2)
- (2)
- (2)
- (2)
- (1)
- (2)
- (3)
- (1)
- (157)
- (1)
- (3)
- (1)
- (5)
- (10)
- (26,072)
- (1)
- (2)
- (1)
- (21)
- (1)
- (12,637)
- (1,160)
- (2)
- (2)
- (8)
- (1)
- (116)
- (8)
- (2)
- (1)
- (8)
- (1)
- (1)
- (1)
- (41)
- (256)
- (158)
- (2)
- (7)
- (1)
- (1)
- (3)
- (4)
- (1)
- (11,340)
- (25)
- (3)
- (30)
- (14)
- (15)
- (73)
- (13)
- (76)
- (81)
- (34)
- (1)
- (13)
- (1)
- (1,153)
- (1)
- (157)
- (26)
- (8)
- (1)
- (2)
- (2)
- (1)
- (18)
- (2)
- (21,642)
- (2,889)
- (4)
- (1)
- (2,842)
- (4)
- (6)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (11,319)
- (3)
- (6)
- (1)
- (1)
- (6)
- (7)
- (5)
- (1)
- (6)
- (1)
- (5,588)
- (6)
- (4)
- (3)
- (12)
- (2)
- (4)
- (5)
- (4)
- (5)
- (1)
- (13,022)
- (1,867)
- (1)
- (1)
Conjugate
- (14)
- (1)
- (4)
- (2)
- (9)
- (8)
- (1)
- (56)
- (1)
- (3)
- (1)
- (1)
- (3)
- (2)
- (1)
- (9)
- (2)
- (1)
- (22)
- (5)
- (1)
- (2)
- (3)
- (36,121)
Recombinant
- (70)
- (34,960)
Form
- (1)
- (23,089)
- (9,235)
- (31)
- (146)
- (26)
- (35)
Regulatory Status
- (79)
- (30,609)
Showing products from the Recombinant Proteins category.
View All Search Results
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Search Within Results
Keyword Search:
Clear All
1
–
15
of
40,390
results
R&D Systems™ Recombinant Human HO-2/HMOX2 Protein
A Novus product, part of R&D Systems. Highly purified. Generating reliable and reproducible results.
Invitrogen™ eBioscience™ Concanavalin A (Con A) Solution (500X)
The Concanavalin A (Con A) Solution (500X) is a ready-to-use solution of Con A in aqueous buffer.
| Format | Vial |
|---|---|
| Form | Solution |
| Source | Canavlia Ensiformis |
| Product Line | eBioscience |
| Protein Subtype | Lectins |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Gene Symbol | EGF |
| Endotoxin Concentration | <0.1 EU/μg |
| Sequence | NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human EGF, Animal-Free |
| Accession Number | P01133 |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Biological Activity | The ED50 was determined by a cell proliferation assay using balb/c 3T3 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 1950 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | Oncostatin M |
| Molecular Weight (g/mol) | 23.6 kDa |
| Gene Symbol | OSM |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | AAIGSCSKEY RVLLGQLQKQ TDLMQDTSRL LDPYIRIQGL DVPKLREHCR ERPGAFPSEE TLRGLGRRGF LQTLNATLGC VLHRLADLEQ RLPKAQDLER SGLNIEDLEK LQMARPNILG LRNNIYCMAQ LLDNSDTAEP TKAGRGASQP PTPTPASDAF QRKLEGCRFL HGYHRFMHSV GRVFSKWGES PNRSRRHSPH QALRKGVRR |
| Expression System | E. coli |
| For Use With (Application) | Control,Bioactivity |
| Source | E. coli |
| Name | Human Oncostatin M (209 aa) |
| Accession Number | P13725 |
| Gene Alias | MGC20461; OncoM; oncostatin M; oncostatin-M; OSM |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 2.0 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg |
| Gene ID (Entrez) | 5008 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human EGF |
| Purification Method | Purified |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Stem Cell Research, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | EGF |
| Storage Requirements | 4°C |
| Protein Subtype | EGF (Epidermal Growth Factor) |
| Accession Number | P01133 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 1950 |
| Product Line | Gibco |
| Purity or Quality Grade | ≥ 97% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 26 kDa |
| Common Name | Activin A |
| Gene Symbol | Inhba |
| Activity | The ED50 as determined by its ability to inhibit the proliferation of murine MPC-11 cells is ≤ 2.0 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg. |
| Endotoxin Concentration | <1 EU/μg |
| Storage Requirements | -20°C |
| Sequence | GLECDGKVNI CCKKQFFVSF KDIGWNDWII APSGYHANYC EGECPSHIAG TSGSSLSFHS TVINHYRMRG HSPFANLKSC CVPTKLRPMS MLYYDDGQNI IKKDIQNMIV EECGCS |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control |
| Name | Human/Mouse/Rat Activin A |
| Accession Number | P08476, P18331, Q04998 |
| Purification Method | Purified |
| Gene Alias | activin A; activin beta-A chain; BMP7; BMP-7; Bone morphogenetic protein 7; EDF; Eptotermin alfa; erythroid differentiation factor; erythroid differentiation protein; follicle-stimulating hormone-releasing protein; FRP; FSH-releasing protein; INHB; Inhba; inhibin B subunit; inhibin beta A chain; inhibin beta A protein; inhibin beta A subunit; inhibin beta-A; inhibin beta-A-subunit; inhibin beta-subunit; inhibin subunit beta A; inhibin, beta A; inhibin, beta A (activin A, activin AB alpha polypeptide); Inhibin, beta-1; OP1; OP-1; Osteogenic protein 1; unnamed protein product |
| Product Type | Protein |
| Gene ID (Entrez) | 16323, 29200, 3624 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | Prolactin |
| Molecular Weight (g/mol) | 23 kDa |
| Gene Symbol | PRL |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MLPICPGGAA RCQVTLRDLF DRAVVLSHYI HNLSSEMFSE FDKRYTHGRG FITKAINSCH TSSLATPEDK EQAQQMNQKD FLSLIVSILR SWNEPLYHLV TEVRGMQEAP EAILSKAVEI EEQTKRLLEG MELIVSQVHP ETKENEIYPV WSGLPSLQMA DEESRLSAYY NLLHCLRRDS HKIDNYLKLL KCRIIHNNNC |
| Expression System | E. coli |
| For Use With (Application) | Control,Bioactivity |
| Source | E. coli |
| Name | Human Prolactin |
| Accession Number | P01236 |
| Gene Alias | AV290867; decidual prolactin; GHA1; growth hormone A1; Human prolactin; lactogenic prehormone (AA -30 to 199); preprolactin; pre-prolactin; Prl; Prl1a1; PRLB; PRLSD1; Prol; Prolactin; prolactin family 1, subfamily a, member 1; prolactin precursor; prolactin protein; RATPRLSD1; RNPROL |
| Biological Activity | Determined by its ability to induce the proliferation of rat Nb2-11 cells in the concentration range of 0.1-1.0 ng/ml |
| Gene ID (Entrez) | 5617 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Protein Family | Growth Factors & Receptors |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | TGF beta-1 |
| Molecular Weight (g/mol) | 25 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Gene Symbol | Tgfb1 |
| Endotoxin Concentration | <0.1 ng/μg |
| For Use With (Application) | Bioactivity |
| Protein Subtype | TGFs (Transforming Growth Factors) |
| Name | Human TGF-beta 1 |
| Accession Number | P01137 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | CED; cytokine; DPD1; LAP; Latency-associated peptide; prepro-transforming growth factor beta-1; regulatory protein; TGF b; TGF b 1; TGF beta; tgf beta 1; tgf beta1; TGF beta-1; TGF beta-1 protein; TGF β; TGF β 1; TGF β1; Tgfb; TGFB1; TGF-B1; Tgfb-1; TGFbeta; TGF-beta 1; TGF-beta 1 protein; TGFbeta1; TGF-beta1; TGF-beta-1; TGFβ1; Transforming growth factor; transforming growth factor b1; transforming growth factor beta; transforming growth factor beta 1; transforming growth factor beta-1; Transforming growth factor beta-1 proprotein; transforming growth factor beta-1 proprotein; transforming growth factor beta-1; transforming growth factor β1; transforming growth factor, beta 1; transforming growth factor, beta 1 (Camurati-Engelmann disease); transforming growth factor, beta-1; transforming growth factor-beta 1; transforming growth factor-beta I; transforming growth factor-beta-1; transforming growth factor-beta-1 precursor; unnamed protein product |
| Protein Form | Recombinant, Ligand |
| Product Type | Protein |
| Gene ID (Entrez) | 7040 |
| Research Category | Immunology, Neurobiology, Oncology, Stem Cell Research, Cardiovascular Research, Differentiation, Bone Research |
| Species | Human |
| Product Line | Gibco |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 23.9 kDa |
| Common Name | BMP4 |
| Gene Symbol | BMP4 |
| Activity | Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells. The expected ED50 for this effect is 5-10 ng/ml. |
| Endotoxin Concentration | <1 EU/μg |
| Storage Requirements | -20°C |
| Sequence | KKNKNCRRHS LYVDFSDVGW NDWIVAPPGY QAFYCHGDCP FPLADHLNST NHAIVQTLVN SVNSSIPKAC CVPTELSAIS MLYLDEYDKV VLKNYQEMVV EGCGCR |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control,Western Blot Control |
| Name | Human BMP-4 |
| Accession Number | P12644 |
| Purification Method | Purified |
| Gene Alias | BMP; BMP2B; BMP-2B; Bmp2b1; Bmp2b-1; Bmp4; Bmp-4; BOMPR4A; Bone morphogenetic protein; Bone morphogenetic protein 2B; bone morphogenetic protein 4; bone morphogenetic protein 4 preproprotein; DVR4; Dvr-4; MCOPS6; OFC11; ZYME |
| Product Type | Protein |
| Gene ID (Entrez) | 652 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | FGF2 |
| Molecular Weight (g/mol) | 17.2 kDa |
| Gene Symbol | FGF2 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | AAGSITTLPA LPEDGGSGAF PPGHFKDPKR LYCKNGGFFL RIHPDGRVDG VREKSDPHIK LQLQAEERGV VSIKGVCANR YLAMKEDGRL LASKCVTDEC FFFERLESNN YNTYRSRKYT SWYVALKRTG QYKLGSKTGP GQKAILFLPM SAKS |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human FGF-basic (FGF-2/bFGF) (154 aa) |
| Accession Number | P09038 |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); Fibroblast growth factor basic; HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Biological Activity | Determined by a cell proliferation assay using Balb/c 3T3 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 2247 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | ≥98% by SDS-PAGE and HPLC |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IGF1 |
| Molecular Weight (g/mol) | 7.5 kDa |
| Endotoxin Level | <1 EU/ml |
| Activity | ED50 ≤ 2 ng/mL; determined by the dose-dependent proliferation of FDC-P1 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human IGF-I |
| Purification Method | Purified |
| Gene Alias | C730016P09Rik; class 1 insulin-like growth factor I preproprotein; class 2 insulin-like growth factor I preproprotein; H-IGF-1; IBP1; IGF; IGF1; Igf-1; IGF1A; IGFI; Igf-I; IGFIa; IGF-IA; IGF-IB; insulin growth factor-1; Insulin like growth factor; insulin like growth factor 1; insulin-like growth factor 1; insulin-like growth factor 1 (somatomedin C); insulin-like growth factor I; insulin-like growth factor I (somatomedin C); insulin-like growth factor IB; mechano growth factor; MGF; M-IGF-1; OTTHUMP00000195084; prepro-IGF-I; prepro-insulin-like growth factor I; R-IGF-1; somatomedin; Somatomedin C; Somatomedin-C |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 ≤ 2 ng/mL; determined by the dose-dependent proliferation of FDC-P1 cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Neurobiology, Drug Development, Oncology, Signal Transduction |
| Species | Human |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
| Bioassay | proliferation of mouse FDC-P1 cells |
| Gene Symbol | IGF1 |
| Sequence | GPETLCGAEL VDALQFVCGD RGFYFNKPTG YGSSSRRAPQ TGIVDECCFR SCDLRRLEMY CAPLKPAKSA |
| Storage Requirements | -20°C |
| Protein Subtype | IGFs (Insulin-Like Growth Factors) |
| Accession Number | P05019 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 3479 |
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 17.3 kDa |
| Common Name | IL-1 beta |
| Gene Symbol | IL1B |
| Activity | The ED50 as determined by the dose-dependent stimulation of thymidine uptake by murine D10S cells is ≤ 1.0 pg/ml, corresponding to a specific activity of ≥ 1 x 10^9 units/mg. |
| Endotoxin Concentration | <1 EU/μg |
| Storage Requirements | -20°C |
| Sequence | APVRSLNCTL RDSQQKSLVM SGPYELKALH LQGQDMEQQV VFSMSFVQGE ESNDKIPVAL GLKEKNLYLS CVLKDDKPTL QLESVDPKNY PKKKMEKRFV FNKIEINNKL EFESAQFPNW YISTSQAENM PVFLGGTKGG QDITDFTMQF VSS |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control,ELISA Standard,Western Blot Control |
| Name | Human IL-1 beta |
| Accession Number | P01584 |
| Purification Method | Purified |
| Gene Alias | catabolin; cytokine; Hematopoietin 1 (H1); IFN beta inducing factor; il 1b; IL 1β; IL-1; IL1 B; IL-1 beta; IL-1 precursor; IL1B; IL-1B; IL1B1; IL1beta; IL-1beta; IL1-BETA; IL1F2; IL1β; ILN; Interleukin; interleukin 1 beta; Interleukin 1 beta precursor; interleukin 1, beta; interleukin 1, beta 1; interleukin 1-beta; interleukin*1*beta; Interleukin1 beta; interleukin-1 beta; interleukin-1 beta precursor; interleukin-1 beta precursor (AA -113 to 153); interleukin-1 beta proprotein; interleukin-1b; interleukin-1beta; interleukin-beta; LAF; lymphocyte proliferation-potentiating factor; Osteoclast activating factor (OAF); preinterleukin 1 beta; Pro interleukin 1 beta; prointerleukin-1 beta; pro-interleukin-1-beta |
| Product Type | Protein |
| Gene ID (Entrez) | 3553 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
